Investor's Business Daily on MSN11h
Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat
Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal ...
MassDevice10h
Stryker will sell spine implant business; CFO set to retire
The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...
Stryker Sells U.S. Spinal Implants Business, CFO To Retire; Sees FY Organic Sales Growth 8.0% - 9.0%
Stryker (SYK) agreed to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm ...
Stryker Sees Further Organic Sales Growth in 2025
Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...
Stryker to Sell Spinal Implants Business to Viscogliosi Brothers
Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York ...
Stryker’s Strong Financial Performance and Strategic Moves Justify Buy Rating
In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...
Earnings call transcript: Stryker Q4 2024 earnings beat forecasts
Stryker Corporation (NYSE:SYK) reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $4.01, compared to the forecasted ...